has been cited by the following article(s):
|
[1]
|
Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular disease
Diabetes & Metabolic Syndrome: Clinical Research & Reviews,
2022
DOI:10.1016/j.dsx.2022.102613
|
|
|
|
|
[2]
|
Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients : what do we know so far ?
Acta Gastro Enterologica Belgica,
2022
DOI:10.51821/85.2.9775
|
|
|
|